STAGE IIIA BREAST CANCER
Clinical trials for STAGE IIIA BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation after mastectomy may cut complications and keep cancer away
Disease control OngoingThis study tests whether a shorter, higher-dose radiation schedule (hypofractionation) after mastectomy works as well as standard radiation in preventing breast cancer from coming back. About 900 people with stage II-IIIa breast cancer who had a mastectomy and reconstruction took…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 01, 2026 20:11 UTC
-
New hope: Pre-Surgery combo shrinks breast tumors, spares healthy tissue
Disease control OngoingThis study tests whether giving chemotherapy (paclitaxel and cyclophosphamide) with or without the targeted drug trastuzumab before surgery can shrink breast tumors and reduce the amount of healthy tissue that needs to be removed. It includes 92 women with early-stage or locally …
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New chemo combo shows promise against tough breast cancer
Disease control OngoingThis study tested a two-drug chemotherapy given before surgery for people with a fast-growing type of breast cancer called triple negative. The goal was to see if the treatment could shrink tumors enough that no cancer remained at the time of surgery. About 67 adults with advance…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New PET scan may predict breast cancer drug success before surgery
Diagnosis OngoingThis study tests whether a special PET scan using copper Cu64-DOTA-trastuzumab can predict how well HER2-positive breast cancer responds to targeted drugs (trastuzumab and pertuzumab) given before surgery. About 18 women with locally advanced breast cancer will receive the scan a…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 01, 2026 20:18 UTC